Use of Somatostatin Analogues in Terminal Cancer Patients

Mercadante S. Treatment of diarrhea due to enterocolic fistula with octreotide in a terminal cancer patient. Pall Med 1992; 6: 257–259.

Mercadante S. , Maddaloni S. Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patients. J Pain Sympt Manag 1992; 7: 496–498.

Stiefel F. , Morant R. Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer. Support Care Cancer 1993; 1: 57–58.

Baines M. , Oliver D.J. , Carter R.L. Medical management of intestinal obstruction in patients with advanced malignant disease. Lancet 1985; 2: 990–993.

Twycross R.G. , Lack S.A. Gastrointestinal obstruction. In: Twycross R.G. , Lack S.A. (eds). Therapeutics in Terminal Cancer, 2nd Edition. London: Churchill Livingston, 1990; 65–68.

Fainsinger R.L. Updating medical management of malignant bowel obstruction. Can J Cont Med Ed 1992; 4: 113–118.

Isbister W.H. , Elder P. , Symons L. Non-operative management of malignant intestinal obstruction. J Roy Coll Surg 1990; 35: 369–372.

Ventafridda V. , Ripamonti C. , Caraceni A. The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 1990; 76: 389–393.

De Conno F. , Caraceni A. , Zecca E. Continuous subcutaneous infusion of hyoscine butylbromide reduces secretions in patients with gastrointestinal obstruction. J Pain Sympt Manag 1991; 6: 484–486.

Fainsinger R. , Spachynski K. , Bruera E. Medical management of malignant bowel obstruction. Presented at the 9th International Congress on Care of the Terminally Ill, Montreal, Quebec, Canada; 31 October – 4 November 1992.